Oncology and Hematology

Jue Wang, M.D.

Dr. WangAssociate Professor, Internal Medicine
Division of Oncology & Hematology

Academic office:
UNMC Oncology/Hematology Division
987680 Nebraska Medical Center
Omaha, NE 681980-7680

Main practice location:
Peggy D. Cowdery Patient Care Center
Lied Transplant Center
987680 Nebraska Medical Center
Omaha, NE 68198-7680
Ph. 402-559-5520
Fax. 402-559-6520

Cancer Center at Village Pointe
111 North 175th Street
Omaha, NE 68118
Ph. 402-596-3100

Education:
University of Texas Medical Branch, Medical Oncology Fellow
University of Texas Medical Branch, Internal Medicine Resident
University of Texas Medical Branch, Hyperbaric Medicine, Chief Fellow
University of Texas Medical Branch, Hyperbaric Medicine, Associate member
University of Texas Medical Branch, Research Fellow
University of Texas Medical Branch, Visiting Scientist
The Institute of Cancer Research, England, Visiting Scientist
SuZhou Medical College, China. Masters Degree of Medical Science
SuZhou Medical College, P R China, MD

Hospital Appointments:
The Nebraska Medical Center University Hospital

Interests:
GU Malignancies
Cancer of unknown primary
Individualized Chemotherapy

Biographical Sketch:
Dr. Jue Wang is an Associate Professor in the Division of Oncology and Hematology in the Department of Internal Medicine at UNMC, specializing in the care of patients with genitourinary cancers. He provides personalized care for cancers of the urinary tract and male genital tract, including prostate, bladder, kidney, testicular, urethral and penile cancer. His goal for patients is cancer control while preserving the best quality of life. Dr. Wang is board certified in both Internal Medicine and Medical Oncology. He is also a Fellow of American College of Physicians (FACP), active member of The American Society of Clinical Oncology (ASCO), The International Society of Gastrointestinal Oncology (ISGIO), and International Society of Geriatric Oncology(SIOG ). 

Select Publications:
Wang J
, Kuo YF, Freeman J, Goodwin JS. Increasing access to medical oncology consultation in older patients with stage II-IIIA non-small-cell lung cancer. Med Oncol. 2008;25(2):125-32. Epub 2007 Sep 5. PubMed PMID: 18488153.

Wang J, Kuo YF, Freeman J, Markowitz AB, Goodwin JS. Temporal trends and predictors of perioperative chemotherapy use in elderly patients with resected non-small cell lung cancer. Cancer. 2008 Jan 15;112(2):382-90. PubMed PMID:18041068.

Wang J, Wang FW, Lagrange CA, Hemstreet GP. Clinical features and outcomes of 25 patients with primary adenosquamous cell carcinoma of the prostate. Rare Tumors. 2010 Sep 30;2(3):e47. PubMed PMID: 21139962; PubMed Central PMCID:PMC2994527. 

Wang J, Wang FW, Lagrange CA, Hemstreet Iii GP, Kessinger A. Clinical features of sarcomatoid carcinoma (carcinosarcoma) of the urinary bladder: analysis of 221 cases. Sarcoma. 2010;2010. pii: 454792. Epub 2010 Jul 18. PubMed PMID: 20706685; PubMed Central PMCID: PMC2913791.

Wang J, Wang FW. Refusal of cancer-directed surgery strongly impairs survival of patient with localized hepatocellular carcinoma. International Journal of Surgical Oncology 2010; doi:10.1155/2010/381795.

Wang J, Wang FW. Clinical characteristics and outcomes of patients with primary signet-ring cell carcinoma of the urinary bladder. Urol Int. 2011;86(4):453-60. Epub 2011 Apr 28. PubMed PMID: 21525723.

Wang J, Kazmi SA. Teratoma with malignant transformation: a case report with pathological, cytogenetic, and immunohistochemistry analysis. Sarcoma. 2011;2011:450743. Epub 2011 Jun 9. PubMed PMID: 21776193; PubMed Central PMCID:PMC3138084.

Wang J, Wang FW, Kessinger A. The natural history and outcomes of the patients with carcinosarcoma involving kidney and renal pelvis. Adv Urol.2011;2011:693964. Epub 2011 Jul 20. PubMed PMID: 21785585; PubMed Central PMCID: PMC3140186.

Wang J, Wang FW, Kessinger A. The impact of signet-ring cell carcinoma histology on bladder cancer outcome. World J Urol. 2011 Jun 25. [Epub ahead of print] PubMed PMID: 21706144.

Wang J, Wang FW. The impact of radical prostatectomy on the survival of patients with carcinosarcoma of the prostate. Journal of Cancer Therapy 2011;2(4):475-480. DOI: 10.4236/jct.2011.24064.

Wang J, Gillaspiea C, Kunadharajua R, Talmon G, Enke C. Sarcomatoid urothelial carcinoma: A single cancer center experience. World J of Oncol. 2011; 2(4): 175-180.

Wang J, Talmon GA, Feloney M, Morris MC. Twelve-year survival after multiple recurrences and repeated metastasectomies for renal cell Carcinoma. World J Surg Oncol. 2011 Nov 28;9(1):155. PubMed PMID: 22123271; PubMed Central PMCID:PMC3239292.

Motzer RJ, Agarwal N, Beard C, Bolger GB, Boston B, Carducci MA, Choueiri TK, Figlin RA, Fishman M, Hancock SL, Hudes GR, Jonasch E, Kessinger A, Kuzel TM, Lange PH, Levine EG, Margolin KA, Michaelson MD, Olencki T, Pili R, Redman BG, Robertson CN, Schwartz LH, Sheinfeld J,Wang J. NCCN clinical practice guidelines in oncology: testicular cancer. J Natl Compr Canc Netw. 2009 Jun;7(6):672-93.PubMed PMID: 19555582.

Motzer RJ, Agarwal N, Beard C, Bolger GB, Boston B, Carducci MA, Choueiri TK, Figlin RA, Fishman M, Hancock SL, Hudes GR, Jonasch E, Kessinger A, Kuzel TM, Lange PH, Levine EG, Margolin KA, Michaelson MD, Olencki T, Pili R, Redman BG, Robertson CN, Schwartz LH, Sheinfeld J,Wang J. NCCN clinical practice guidelines in oncology: kidney cancer. J Natl Compr Canc Netw. 2009 Jun;7(6):618-30. PubMed PMID: 19555584.

;